NIU:NASDAQNiu Technologies Analysis
Data as of 2026-04-20 - not real-time
$3.07
Latest Price
8/10Risk
Risk Level: High
Executive Summary
NIU is trading at $3.07, well below its 20‑day SMA of 2.91 and its 50‑day SMA of 3.29, indicating short‑term weakness, while the 200‑day SMA sits at 3.72 reinforcing a longer‑term bearish bias. The RSI of 50.8 suggests neutral momentum, but the MACD line remains negative (-0.07) despite a bullish histogram, hinting at a potential near‑term reversal that has yet to materialize. Volume is on a decreasing trend and the 30‑day volatility is a lofty 73.5%, amplifying price swings and risk. Fundamentals are shaky: revenue fell 17.4% YoY, gross margin is under 20%, and operating margins are negative, while the forward PE of 10.2 and a target upside of 28.3% imply the stock may be undervalued relative to its peers. Recent news shows Q4 deliveries plunged ~24% YoY due to new e‑bike standards in China, and Q1 sales volume results remain modest, reinforcing the bearish outlook.
Given the high beta (~1.33), elevated sector risk in consumer cyclical auto manufacturing, and concentration in China, investors should treat NIU as a high‑risk play. However, the forward EPS projection of 0.30 and a modest price‑to‑book of 1.87 offer a value angle if the company can navigate regulatory shifts and revive growth. The consensus “buy” rating from two analysts reflects optimism about a turnaround, but the technical and fundamental headwinds suggest caution in the near term.
Given the high beta (~1.33), elevated sector risk in consumer cyclical auto manufacturing, and concentration in China, investors should treat NIU as a high‑risk play. However, the forward EPS projection of 0.30 and a modest price‑to‑book of 1.87 offer a value angle if the company can navigate regulatory shifts and revive growth. The consensus “buy” rating from two analysts reflects optimism about a turnaround, but the technical and fundamental headwinds suggest caution in the near term.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Bearish technical setup (price below all SMAs, negative MACD)
- Decreasing volume and high volatility
- Recent earnings miss and 24% drop in Q4 deliveries
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Forward EPS positivity and 28% upside potential
- Valuation metrics (forward PE ~10, low price‑to‑sales)
- Uncertainty around regulatory changes and recovery of margins
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued price relative to target and fundamentals
- Growth narrative in electric mobility and smart urban solutions
- Potential improvement in margins as scale and new product cycles roll out
Key Metrics & Analysis
Financial Health
Revenue Growth-17.40%
Profit Margin-0.91%
P/E Ratio10.2
ROE-4.29%
ROA-1.98%
Debt/Equity26.96
P/B Ratio1.9
Technical Analysis
TrendBearish
RSI50.8
Support$2.71
Resistance$3.22
MA 20$2.91
MA 50$3.29
MA 200$3.72
MACDBullish
VolumeDecreasing
Fear & Greed Index86.77
Valuation
Target Price$3.94
Upside/Downside28.34%
GradeUndervalued
TypeValue
Risk Assessment
Beta1.33
Volatility73.47%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.